Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
2005 1
2007 1
2008 6
2009 5
2010 4
2011 3
2012 7
2013 4
2014 1
2015 10
2016 6
2017 15
2018 18
2019 19
2020 12
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 23983983

98 results
Results by year
Filters applied: . Clear all
Page 1
Cannabis, a complex plant: different compounds and different effects on individuals.
Atakan Z. Atakan Z. Ther Adv Psychopharmacol. 2012 Dec;2(6):241-54. doi: 10.1177/2045125312457586. Ther Adv Psychopharmacol. 2012. PMID: 23983983 Free PMC article.
Molecular Pharmacology of Phytocannabinoids.
Turner SE, Williams CM, Iversen L, Whalley BJ. Turner SE, et al. Prog Chem Org Nat Prod. 2017;103:61-101. doi: 10.1007/978-3-319-45541-9_3. Prog Chem Org Nat Prod. 2017. PMID: 28120231 Review.
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
Niesink RJ, van Laar MW. Niesink RJ, et al. Front Psychiatry. 2013 Oct 16;4:130. doi: 10.3389/fpsyt.2013.00130. Front Psychiatry. 2013. PMID: 24137134 Free PMC article. Review.
Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.
Burggren AC, Shirazi A, Ginder N, London ED. Burggren AC, et al. Am J Drug Alcohol Abuse. 2019;45(6):563-579. doi: 10.1080/00952990.2019.1634086. Epub 2019 Jul 31. Am J Drug Alcohol Abuse. 2019. PMID: 31365275 Free PMC article. Review.
Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
Millán-Guerrero RO, Isais-Millán S. Millán-Guerrero RO, et al. Gac Med Mex. 2019;155(5):471-474. doi: 10.24875/GMM.M20000334. Gac Med Mex. 2019. PMID: 32091020 Review.
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.
Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Izzo AA, et al. Trends Pharmacol Sci. 2009 Oct;30(10):515-27. doi: 10.1016/ Epub 2009 Sep 2. Trends Pharmacol Sci. 2009. PMID: 19729208 Review.
Recommendation to reconsider examining cannabis subtypes together due to opposing effects on brain, cognition and behavior.
Rømer Thomsen K, Callesen MB, Feldstein Ewing SW. Rømer Thomsen K, et al. Neurosci Biobehav Rev. 2017 Sep;80:156-158. doi: 10.1016/j.neubiorev.2017.05.025. Epub 2017 Jun 1. Neurosci Biobehav Rev. 2017. PMID: 28579491 Free PMC article.
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.
Solowij N, Broyd S, Greenwood LM, van Hell H, Martelozzo D, Rueb K, Todd J, Liu Z, Galettis P, Martin J, Murray R, Jones A, Michie PT, Croft R. Solowij N, et al. Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17-35. doi: 10.1007/s00406-019-00978-2. Epub 2019 Jan 19. Eur Arch Psychiatry Clin Neurosci. 2019. PMID: 30661105 Clinical Trial.
Cannabis with high cannabidiol content is associated with fewer psychotic experiences.
Schubart CD, Sommer IE, van Gastel WA, Goetgebuer RL, Kahn RS, Boks MP. Schubart CD, et al. Schizophr Res. 2011 Aug;130(1-3):216-21. doi: 10.1016/j.schres.2011.04.017. Epub 2011 May 17. Schizophr Res. 2011. PMID: 21592732 Free article.
Cannabis and Neuropsychiatric Disorders: An Updated Review.
Chayasirisobhon S. Chayasirisobhon S. Acta Neurol Taiwan. 2019 Jun 15;28(2):27-39. Acta Neurol Taiwan. 2019. PMID: 31867704 Review.
98 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page